# A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Malignant Neoplasm

- Company: Merck Sharp & Dohme LLC
- Sector: Malignant Neoplasm
- Primary source: https://clinicaltrials.gov/study/NCT07302347

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.